Results
PMID | 27132422 |
Gene Name | PTGS2 |
Condition | Endometriosis |
Association |
Associated |
Mutation | COX-2 (-1195 A/G polymorphism) |
Population size | 89 |
Population details | 89 (32 EM patients with pain, 28 EM patients without pain, and 29 healthy controls) |
Sex | Female |
Other associated phenotypes |
Endometriosis, Endometriosis associated pain |
Clin Exp Obstet Gynecol. 2016;43(2):254-7. Wang, H| Sun, L| Jiang, M| Liu, L| Wang, G OBJECTIVE: The aim of this study was to evaluate the association between -1195 A/G polymorphism in cyclooxygenase-2 (COX-2) gene and the risk of pain occurrence in women with endometriosis (EM). MATERIALS AND METHODS: -1195 A/G polymorphism in the promoter region of COX-2 gene was analyzed in 32 EM patients with pain, 28 EM patients without pain, and 29 healthy controls in a Chinese population using a PCR-RFLP assay. RESULTS: AA homozygote carriers and A allelic frequencies for -1195 A/G polymorphism in COX-2 gene were significantly increased in EM patients compared with the healthy controls (p < 0.001). In addition, further subgroup analysis revealed that the AA genotype and A allele of the -1195 A/G variant were present at a significantly higher frequency in the severe pain group than those in the mild and moderate pain groups. Compared with the controls, the risk of developing EM was 2.86-fold higher in individuals with -1195 AA containing the haplotype, and the risk of developing pain was 2.33-fold higher in EM patients with -1195 AA containing the haplotype. CONCLUSIONS: These findings suggest that the -1195 A/G on the promoter region of COX-2 gene may increase the risk of pain occurrence in EM women, possibly by affecting the rate of gene expression, especially in patients with the pain phenotype. Mesh Terms: Adult| Asian Continental Ancestry Group/genetics| Biological Assay| Case-Control Studies| Cyclooxygenase 2/*genetics| Endometriosis/complications/*surgery| Female| Gene Expression| Gene Frequency| Genotype| Haplotypes| Humans| Ovarian Diseases |